Galectin Therapeutics annual free cash flow
2011
2012
2013
2014
2015
Galectin Therapeutics Free Cash Flow (FCF) History (GALT)
Galectin Therapeutics reported −$17.0M in free cash flow for fiscal 2015, a decrease of $4.6M from the previous fiscal year.
View full Galectin Therapeutics company overviewGalectin Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2015 | 2015-12-31 | −$17.0M | −$4.6M | — | — |
| 2014 | 2014-12-31 | −$12.4M | −$4.9M | — | — |
| 2013 | 2013-12-31 | −$7.5M | $21,000 | — | — |
| 2012 | 2012-12-31 | −$7.5M | −$1.8M | — | — |
| 2011 | 2011-12-31 | −$5.7M | — | — | — |
Galectin Therapeutics quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Galectin Therapeutics free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Galectin Therapeutics filings at SEC.gov ↗